SORT BY

The Future 50

Courtesy of Medidata Solutions
challengers

11

Medidata Solutions

MDSO

Multinational drug developers like GlaxoSmithKline and ­Bristol-Myers Squibb have taken their clinical research and trials to the cloud, thanks to Medidata’s software. Already, the company’s clinical cloud platform is being used by 17 of the top 25 global pharmaceutical companies, and nine of the 10 bestselling drugs in the world were developed on the platform. That success helped push revenues last year to $463 million, up 18% from the previous year. To keep more established competitors like Oracle at bay, Medidata will need to continue diversifying its customer base—the company’s top five customers accounted for approximately a quarter of sales last year.

Looking for leads, investment insights, or competitive intelligence?

Overall Score

3.2

Sector

Health Care

Industry

Health Care: Pharmacy and Other Services

CEO

Tarek A. Sherif

Employees

1,424

HQ Location

New York, N.Y.

Revenues ($M) (Past 12 Months)

$509

Profits ($M) (Past 12 Months)

$36

Market Value as of Oct. 9, 2017 ($M)

$4,717

Revenue and net income for 12 months ended June 30, 2017. Source: S&P Global.
Medidata Solutions is also featured in these fortune lists

News about Medidata Solutions

Boston and New York have same tech startup problem

arod_varitekThe quarterly Boston vs. New York funding debate misses the bigger point.

Read More →